Læknaneminn - 01.04.1994, Síða 74

and ventilatory effect of the morphine metabolites:
morphine-6-glucuronide and morphine-3-glucuronide.
European J of Pharmacology 1991; 193:47-56.
30. P J Hoskin og G W Hanks: Morphine: pharmacokinetics and
clinical practice. Br J Cancer 1990: 62; 705-707.
32. R F Kaiko: Age and morphine analgesia in cancer patient
with postoperative pain. Clin Pharmacology and
Therapeutics 1980; 28: 823-826.
33. C Ripamonti og E Bruera: Rectal, buccal and sublingual
narcotics for the management of cancerpain. J of Palliative
Care 1991; 7:1:30-35.
34. E Bruera o. fl.: Hypodermoclysis for the administration of
fluids in patients with advanced cancer. J Pain Symptom
Management 119; 5: 218-220.
35. DJ Oliver: Syringe drivers in palliative care: a review. Pall
Med 1988; 2: 21-26.
36. RF Kaiko, N Healy, J Pav o. fl.: The comparative
bioavailability of MS Contin® tablets (contolled released
oral morhine) following rectal and oral administration. The
Edinburgh Symposium on Pain control and medical
eduction. (Ritstj. RG Twycross). London, Royal Society of
Medicine 1989; 235-241.
37. H T Bezon: Epidural steroid injections for low back pain and
lumbosacral radiculopathy. Pain 1986; 27: 277-295.
38. S Ottesen, M Minton, RG Twycross: The use of epidural
morphine at a palliative care centre. Pall Med 1990; 4: 117-
122.
39. Hanks GW, Twycross RG, Lloyd JW: Unexpected
complications of successful nerve block. Br J Anaesthesia
1981; 36: 37-39.
40. Writer o.fl: Canadian Anaesthesiol Society Joumal 1985; 32:
330-338.
41. I E Kiss, B Simini, J W May: Effect of epidural morphine on
various kinds of cancerpain. Pall Med 1989; 3:217-221.
42. M Hunt, J Massalino: Spinal bupivacaine for the pain of
cancer. Med J of Australia 1989; 150: 350-356.
43. C Glynn og K O'Sullivan: A double blind randomized
comparison of the neurological effects of epidural
clonidine, lignocaine and the combination of clonidine and
lignocaine in patients with chronic pain. 7th World congress
on pain, Paris 1993: úrdráttur 233.
44. Tamsen A & Gordh T.: Epidural clonidine produces
analgesia. Lancet 1984; i: 231-232.
45. R Portenoy og K Foley: Management of cancer pain. I:
Holland JC and Rowland JH.: Handbook of
Psychooncology. Psychological Care of the Patient with
Cancer. Oxford University Press 1991; 369-382.
46. W Breitbart: Psychiatric management of cancer pain. Cancer
1989: 63: 2336-2342.
47. F Kozin, L M Ryan, G F Carrera o. fl.: The reflex
sympathetic dystrophy syndrome (RSDS). III.
Scientigraphic studies, further evidence for the therapeutic
efficacy of systemic corticosteroids, and proposed diagnostic
criteria. Am J Medicine 1981; 70: 23-29.
48. A B Ettinger, R K Portenoy: The use of corticosteroids in
the treatment of symptoms associated with cancer. J Pain
and Symptom Management 1988; 3: 99-103.
49. Walsh, TD, Baxter R, Bowman K et al.: High-dose
morphine and respiratory function in chronic cancer pain.
Pain 1981, Suppl 1: 39-
50. C J Getto, C A Sorkness og T Howell: Antidepressants and
chronic non-malignant pain: A review. J Pain Sympt Manag
1987; 2: 9-18.
51. Hanks GW: The pharmacological treatment of bone pain.
Cancer Surv 1988; 7: 87-101
52. Twycross RG, Fairfield S: Pain in far advanced cancer. Pain
1982; 14: 303-310.
53. Bennet A: The role of biochemical mediators in peripheral
nociception and bone pain. Cancer Surv 1988; 7: 55-67.
54. Ferreira SH: Prostaglandins, aspirin-like drugs and
analgesia. Nature 1972; 240; 200-203.
55. H S Greenberg, M D F Beck, B Vikram o.fl.:Metastases to
the base of the skull: Clinical ftndings in 43 patients.
Neurology 1981;31:530-535.
56. K Elliot ogKM Foley: Neurologic pain syndromes in
patients with cancer. Crit Care Clin 1990; 6: 393-397.
57. Rowell NP: Intralesional methylprednisolone for rib
metastases: an altemative to radiotherapy? Pall Med 1988; 2:
153-155.
58. Bates TD: The management of bone metastases:
radiotherapy. Pall Med 1987; 1:117-120.
59. OS Nielsen, AJ Munro, IF Tannock: Bone metastases:
Pathophysiology and management policy. J Clin Oncol
1991; 9: 509-524.
60. R E Coleman, P J Woll, M Miles et al: Treatment of bone
metastases from breast cancer with (3-amino-l-
hydroxyprolidene)-l,l-bisphoshonate (APD). Br J Cancer
1988; 58:621-625.
61. J Tennvall, L Darte, R Lundgren o.fl.: Palliation of multiple
bone metastases from prostate carcinoma with strontium-89.
Acta Oncol 1988; 27:365-369.
62. Matthews MJ: Problems in morphology and behaviour of
bronchopulmonary malignant disease. I Israel L, Chahanian
P [ritstj. ]: Lung Cancer: Natural History, Prognosis and
Therapy; New York Academic Press, 1976; 23-62,
63. Bunn.PA et al.: Central nervous metastases in small cell
bronchogenic carcinoma. Semin Oncol 1978; 5:314-322
64. J D Loeser og M J Cousins: Contemporary pain
management. Med J of Australia 1990; 153: 208-216.
65. S A Grossman, V R Sheidler, K Swedeen o.fl.: Correlation
of patient and caregiver ratings of cancer pain. J Pain
Symptom Manage 1991; 6:53-57.
66. J Weeks: Quality of life assessment: Performance status
upstaged? (Ritstjómargrein). J ofClin Oncol 1992; 10(12):
1827-1829.
66. CR Chapman, KL Casey, R Dubner o.fl.: Pain measurement:
Anoverview. Pain 1985; 22: 1-15.
67. Vilhjálmur Amason : Tæknivæðing og siðvæðing. I:
Siðfræði lífs og dauða. Háskóli Islands, Rannsóknarstofnun
í siðfræði, Reykjavík 1993: 25-30.
69. Committee on cancer pain of the ASCO: Cancer pain
assessment and treatment curriculum guidelines. J Clin
Oncol 1992; 10: 1976-1982.
70. M B Max: Improving outcomes af analgesic treatment: Is
education enough? Annals of Int Medicine 1990; 113:885-
889.
68
LÆKNANEMINN 1 1994 47. árg.